These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2060980)

  • 21. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP; Wetsteyn JC; Meuwissen JH
    Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imported cases of chloroquine-resistant falciparum malaria in Iran.
    Edrissian GH; Shahabi S; Pishva E; Hajseyed-Javadi J; Khaleghian B; Ghorbani M; Emadi AM; Afshar A; Saghari H
    Bull Soc Pathol Exot Filiales; 1986; 79(2):217-21. PubMed ID: 3524879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren.
    Landgraf B; Kollaritsch H; Wiedermann G; Wernsdorfer WH
    Trans R Soc Trop Med Hyg; 1994; 88(4):440-2. PubMed ID: 7570837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-resistant falciparum malaria among the Mayongong Indians in the Brazilian Amazon.
    Ferraroni JJ; Hayes J
    Am J Trop Med Hyg; 1979 Sep; 28(5):909-11. PubMed ID: 384818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
    Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector.
    Hogh B; Gamage-Mendis A; Butcher GA; Thompson R; Begtrup K; Mendis C; Enosse SM; Dgedge M; Barreto J; Eling W; Sinden RE
    Am J Trop Med Hyg; 1998 Feb; 58(2):176-82. PubMed ID: 9502601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988.
    Hansford CF
    S Afr Med J; 1989 Nov; 76(10):546-7. PubMed ID: 2686047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
    Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Falciparum malaria resistant to chloroquine, quinine and Fansidar in a non-immune patient infected in Ghana.
    Nguyen C; Gregson D; Mouldey P; Keystone JS
    Trans R Soc Trop Med Hyg; 1989; 83(4):485-6. PubMed ID: 2694485
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chloroquine and pyrimethamine/sulfadoxine resistant malaria tropica in a child with diabetes mellitus].
    Kroll MH; Bienzle U; Burger W; Weber B
    Monatsschr Kinderheilkd; 1984 May; 132(5):301-2. PubMed ID: 6379425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology of drug-resistant malaria.
    Björkman A; Phillips-Howard PA
    Trans R Soc Trop Med Hyg; 1990; 84(2):177-80. PubMed ID: 2202097
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
    Niklewski G; Landscheidt H; Glasner H
    Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058
    [No Abstract]   [Full Text] [Related]  

  • 33. [In vivo resistance of Plasmodium falciparum to 4-aminoquinolines and to a sulfadoxine-pyrimethamine combination. II. Study of Manaus, Amazonas 1983-1984].
    Reyes S; Osanai CH; Passos AD
    Rev Bras Malariol Doencas Trop; 1986; 38():37-44. PubMed ID: 3077193
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chloroquine-resistant Plasmodium falciparum malaria confirmed by semi-micro sensitivity test for chloroquine seen in a person returned from Nigeria to Japan].
    Obana M; Yamakawa H; Matsuoka Y; Kano S; Waki S; Suzuki M
    Kansenshogaku Zasshi; 1989 Jan; 63(1):83-8. PubMed ID: 2501425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-resistant malaria in Africa. A case report and review of the problem and treatment.
    Nieuwveld RW; Halkett JA; Spracklen FH
    S Afr Med J; 1982 Jul; 62(6):173-5. PubMed ID: 7046105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity in vivo of Plasmodium falciparum to chloroquine and pyrimethamine/sulfadoxine in a coastal area of Tanzania.
    Hedman P; Rombo L; Björkman A; Brohult J; Kihamia CM; Potter J; Stenbeck J
    Ann Trop Med Parasitol; 1986 Feb; 80(1):7-11. PubMed ID: 3524485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chloroquine-resistant Plasmodium falciparum malaria in South Africa. A case report.
    Visagie NJ; Sieling WL
    S Afr Med J; 1985 Oct; 68(8):600-1. PubMed ID: 3901327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined chloroquine/Fansidar-resistant falciparum malaria appears in East Africa.
    Hess U; Timmermans PM; Jones M
    Am J Trop Med Hyg; 1983 Mar; 32(2):217-20. PubMed ID: 6340538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Malaria caused by multi-resistant Plasmodium falciparum contracted in Tanzania].
    Mazier D; Danis M; Druilhe P; Karabinis A; Brucker G; Félix H; Gentilini M
    Bull Soc Pathol Exot Filiales; 1984; 77(1):44-51. PubMed ID: 6373034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative efficacy of alternative treatments in Plasmodium falciparum infections in Zaire].
    Mbudi PK; Pela NN; Kalonji MW; Disu MM
    Ann Soc Belg Med Trop; 1989 Mar; 69(1):25-33. PubMed ID: 2658877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.